Testing a new blood typing card for transfusions
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This trial tests a new device called the ABTest Card that checks your blood type from a finger prick. It may help make blood transfusions safer and faster for people who need them.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older, or a newborn needing a blood transfusion.
- You need a blood transfusion or a routine newborn blood test.
- You have health insurance.
- You or your legal representative can sign a consent form.
- You are not pregnant, not in custody, not unconscious, and not under guardianship.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new device that checks your blood type before a transfusion. It is designed for adults who need blood and for newborns who need routine blood tests.
This study tests a new blood testing device on healthy adults to see if it works well and is easy to use. It may help improve how blood tests are done in the future.
This study checks if a special treatment to reduce germs in red blood cells is safe for patients who may have developed antibodies from past transfusions. You will receive a small transfusion of these treated cells to see how your body reacts.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
This study tests a special system (Hemanext One) that stores red blood cells with less oxygen, to see if it helps people with thalassemia who need regular transfusions. It may reduce side effects or improve how well the transfusions work.
This study tests an experimental drug called YOLT-204 to see if it is safe and can help people with transfusion-dependent beta-thalassemia need fewer blood transfusions. It is for adults aged 18 to 35 who have a specific type of thalassemia and are otherwise healthy enough for the trial.
Hear when a new Transfusion Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.